Engineered Nanozymes Sensitize Liver Cancer Cells to Chemotherapy in Preclinical Testing
Researchers designed multifunctional gambogic acid-iron-doxorubicin nanozymes that trigger reactive oxygen species generation and overcome resistance mechanisms in liver cancer models.

